Dr. David Hong, MD
Claim this profileM D Anderson Cancer Center
Area of expertise
Pancreatic Cancer
David Hong, MD has run 14 trials for Pancreatic Cancer. Some of their research focus areas include:
Solid Tumors
David Hong, MD has run 11 trials for Solid Tumors. Some of their research focus areas include:
Affiliated Hospitals
M D Anderson Cancer Center
The University Of Texas M.D. Anderson Cancer Center
Clinical Trials David Hong, MD is currently running
Larotrectinib
for Advanced or Metastatic Cancer
This phase II trial studies the effect of larotrectinib in treating patients with NTRK gene amplification positive solid tumors that have spread to nearby tissues or lymph nodes (locally advanced) or other places in the body (metastatic). Larotrectinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting
1 award
Phase 2
14 criteria
NK Cell Therapy + Chemotherapy
for Advanced Kidney, Lung, or Bone Cancer
To find a recommended dose of donated NK cells that can be given with lymphodepleting chemotherapy to patients with advanced renal cell carcinoma, mesothelioma, or osteosarcoma. The effects of this therapy will also be studied.
Recruiting
1 award
Phase 1 & 2
13 criteria
More about David Hong, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 32 trials as a Principal Investigator · 10 Active Clinical Trials
Treatments David Hong, MD has experience with
- Pembrolizumab
- Cetuximab
- Radiation Therapy
- ADP-A2M4CD8
- Ipilimumab
- Irinotecan Hydrochloride
Breakdown of trials David Hong, MD has run
Pancreatic Cancer
Solid Tumors
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Hong, MD specialize in?
David Hong, MD focuses on Pancreatic Cancer and Solid Tumors. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is David Hong, MD currently recruiting for clinical trials?
Yes, David Hong, MD is currently recruiting for 10 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that David Hong, MD has studied deeply?
Yes, David Hong, MD has studied treatments such as Pembrolizumab, Cetuximab, Radiation Therapy.
What is the best way to schedule an appointment with David Hong, MD?
Apply for one of the trials that David Hong, MD is conducting.
What is the office address of David Hong, MD?
The office of David Hong, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.